Cardiovascular Systems (CSI), a developer of interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc, based in Aichi, Japan, to market its peripheral guidewire line in the United States.
“Asahi peripheral guidewires address long, complex lesions above or below the knee, and complement the plaque removal capabilities of our Diamondback 360° atherectomy device,” said David L. Martin, CSI president and CEO.
The St. Paul, Minn-based CSI said its Diamondback 360° peripheral arterial disease (PAD) system is a minimally invasive atherectomy system for treating PAD. The company will offer two Asahi 0.18 wire platforms: the Astato 30 and Treasure 12. The Astato 30 is a guidewire designed to break through fibrous caps and calcium deposits, and treat long, complex lesions. The Treasure 12 has a one-piece core.